KELIN presents TB data findings on vulnerable and undeserved populations February 14, 2018 On 5 – 6 February 2018, KELIN participated in a two day workshop to evaluate the data for action for TB key, vulnerable and underserved
African Civil Society Groups Challenge Gilead’s Lenacapavir Prodrug Patent Application at ARIPO September 11, 2026
From Patents to Patients : Senegal Explores New Pathways to Improve Access to Medicines August 31, 2026